Study on prolonged administration interval of triptorelin for post-operative endometriosis

In: 国际医药卫生导报 · 2018 · vol. 24(14) , pp. 2067–2069 · doi:10.3760/cma.j.issn.1007-1245.2018.14.003 · W3032292323
article OA: closed CC0
View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-07

Administering triptorelin every five weeks post-operatively for stage 3-4 endometriosis showed similar estrogen levels but a delayed menstrual recovery compared to the four-week interval.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objective To evaluate the feasibility of prolonged administration interval of triptorelin for post-operative endometriosis. Methods 89 women with stage 3-4 endometriosis were randomly assigned to a study group (42 cases) and a control group (47 cases). The observation group were intramuscularly injected 3.75 mg triptorelin every 5 weeks after operation, and the control group every 4 weeks. Results During the treatment, there was no statistical difference in estrogen level between these two groups. The menstruation recovery time was (234.0±17.1) days in study group, and was (209.0±13.6) days in control group. Conclusions The injection of triptorelin every 5 weeks after operation for patients with stage 3-4 endometriosis is feasible. Key words: Endometriosis; Ovarian chocolate cyst; Gonadotropin-releasing hormone agonist; Triptorelin

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK